🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts said the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the service has taken down violative material and prohibited related hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with images of weight loss, positive reviews and step-by-step guides for preparing or administering at residence.

Within minutes of entering one community, a seller shared contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Product Details and Costs

Inside these groups, messages display black plastic packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the research behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially serious medical dangers”.